Quotient Sciences Quotient Sciences

X

Find the latest Drugs in Development and Pipeline Prospector News of Pfizer CentreOne.

  • Webinars & Exhibitions

  • Dexamethasone

  • Dexamethasone 9,11-Epoxide

  • Dexamethasone Acetate

  • Dexamethasone Sodium Phosphate

  • Hydrocortisone

  • Hydrocortisone (Cortisol)

  • Hydrocortisone Acetate

  • Hydrocortisone Hemisuccinate Hydrate

  • Medroxyprogesterone Acetate

  • Megestrol Acetate

  • Progesterone

  • API Clinical & Commercial Supply

PharmaCompass
left grey arrow
right gray arrow

Details:

Enterin completed the first human clinical trials for ENT-01 which demonstrated that oral administration of its treatment has restored function of the nervous system of the gastrointestinal tract in Parkinson’s patients.


Lead Product(s): ENT-01

Therapeutic Area: Neurology Product Name: ENT-01

Highest Development Status: Phase IIProduct Type: Small molecule

Partner/Sponsor/Collaborator: Enterin

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration March 28, 2022

Details:

Enviero is first-of-its-kind, a green-chemistry progesterone that represents a step change in progesterone API synthesis, is manufactured via a proprietary biocatalytic process based on plant sterols that reduce waste, greenhouse gas emissions and use of hazardous solvents.


Lead Product(s): Progesterone

Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Product Name: Estima

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Effik

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable November 18, 2020

Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY